Pharmacy Benefits Management Services Home

10 mg: -46%, -32%, 84% Yoshika (2010) PC N = 30 Pitava 2 vs. Pcb 52 Primary Endpoint: hsCRP level at 52 weeks. hsCRP level at 52 weeks: Absolute values similar between groups at 52 weeks Gumprecht (2011) R, DB, AC, NI N = 399 Pitava 4 vs. Atorva 20 12 (Ext. Study 44) Primary Endpoint: Δ in LDL in patients with type 2 DM and combined dyslipidemia ................
................